Silexion Therapeutics Corp: memorandum amended to increase authorized share capital

What happened Silexion Therapeutics Corp announced that at an extraordinary general meeting originally held on Oct 19, 2026 and reconvened on Oct 26, 2026, shareholders approved a resolution serving as an effective amendment to paragraph 5 of the company’s amended and restated memorandum of association (the "Memorandum Amendment") that increased the company’s authorized share capital. The Memorandum Amendment was filed with the Registrar of Companies of the Cayman Islands on Oct 26, 2026 and became effective on filing.

Key details

• Extraordinary general meeting originally held Oct 19, 2026 and reconvened Oct 26, 2026.
• Shareholders approved an amendment to paragraph 5 of the amended and restated memorandum of association.
• The Memorandum Amendment was filed with the Registrar of Companies of the Cayman Islands on Oct 26, 2026 and became effective that day.

Why it may matter The filing reports Item 5.03 (amendments to articles of incorporation or bylaws) and Item 5.07 (submission of matters to a vote of security holders); Item 5.03 covers changes to the company’s governing documents and Item 5.07 covers the shareholder vote. This filing does not show why the insider traded or why the company acted.